Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options.
about
Oligodendroglial membrane dynamics in relation to myelin biogenesisDeveloping therapeutic approaches for metachromatic leukodystrophyNovel patient cell-based HTS assay for identification of small molecules for a lysosomal storage diseaseLanguage and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort.Induced pluripotent stem cell models of lysosomal storage disorders.Cerebral gray and white matter changes and clinical course in metachromatic leukodystrophy.Mesenchymal stem cells as cellular vectors for pediatric neurological disordersOligodendrocyte loss during the disease course in a canine model of the lysosomal storage disease fucosidosisDopamine receptors in human adipocytes: expression and functionsUnrelated umbilical cord blood transplant for juvenile metachromatic leukodystrophy: a 5-year follow-up in three affected siblings.Arylsulfatase A deficiency causes seminolipid accumulation and a lysosomal storage disorder in Sertoli cellsSulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophyCNS-directed gene therapy for lysosomal storage diseasesLong-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report.Umbilical cord blood transplantation for juvenile metachromatic leukodystrophy.Inherited metabolic disorders involving the eye: a clinico-biochemical perspective.Lysosomal lipid storage diseases.Gene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseases.Metachromatic Leukodystrophy (MLD): a Pakistani Family with Novel ARSA Gene Mutation.Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases.Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy.The natural course of gross motor deterioration in metachromatic leukodystrophy.Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy.Ultra-performance liquid chromatography/tandem mass spectrometry for determination of sulfatides in dried blood spots from patients with metachromatic leukodystrophy.Metachromatic leukodystrophy: natural course of cerebral MRI changes in relation to clinical course.Metachromatic leukodystrophy and its effects on the gallbladder: a case report.Pathology of the gallbladder in a child with metachromatic leukodystrophy.Nonclinical comparability studies of recombinant human arylsulfatase A addressing manufacturing process changes.Development of the Impact of Juvenile Metachromatic Leukodystrophy on Physical Activities scale
P2860
Q26753112-32052389-9FA1-460F-9F37-3FEF20334A9DQ28297086-112E7513-C5FB-4560-89CE-A0C4D0FFEEB0Q28478533-6B93DEF8-0F79-422D-B280-0E8E4D73FC8DQ30443114-E0514FBE-3E60-4734-872C-6438FEADD1B1Q33830512-3FE7CF4E-0BBD-4302-BBFA-B19F9C810ECDQ33903446-BA25CFEE-F2EC-497C-A979-ACDF585DF533Q33918923-379A4252-138F-4F99-812E-7D9C2CF45FBAQ33980271-ED901C83-2CC6-44A8-B533-3A0E601DA828Q34038390-AFA30F3B-172A-4190-B9A5-B5022D33BFDBQ34645266-C60B7E62-56BE-48A8-B44D-A1FBFA050F74Q35561966-03B5BB7F-67F5-4D7F-973C-4D589D922E6DQ35619201-8FE8C07C-EF19-40CD-A961-4817E15A5096Q35923467-2E5F9DEE-FB6C-44A1-B30B-7036C0686974Q35985930-E9A78959-26C5-44D0-B380-08758A522696Q37019501-0EE5910F-C9D3-4619-8061-DBB9B893B7FAQ37607099-EBF3D744-D59F-44A1-A594-F96D0A5B8710Q37866549-4304CC48-600A-4933-B0BB-E8729BC40D88Q37994717-610D6A9C-6EBF-4B25-98FA-6AC4F23FC07EQ38629349-AD4D44CA-CA04-43FC-9F11-9EAE56553539Q38999340-A21C5277-BF8B-47E0-BF19-ED8405C6FB9DQ40196566-C2114E96-3FB6-4B47-A3B7-C59E853765CBQ44620592-CCD451CC-D7CB-42F3-B9F7-3EDAC20179AFQ46501666-67C6A2EB-E8C2-4003-AE9A-C2041FE5B126Q46932953-E697A35C-8B8C-4621-9F73-20C09EF3DA13Q49136026-985E20FA-EE7C-4733-998B-8A0267BAA421Q50176072-C77A7BA0-51D9-4938-BAC2-FAA7B74085B4Q53650470-29C68108-E6AD-4CFE-BFC6-EFAB8F57084BQ55209626-FC32D68D-FD95-4212-BBB6-3BCE4093802EQ56764352-D0754177-14B7-42EC-84CC-AF18384CB2C4
P2860
Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options.
@en
type
label
Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options.
@en
prefLabel
Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options.
@en
P2860
P1433
P1476
Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options.
@en
P2093
Volkmar Gieselmann
P2860
P356
10.1111/J.1651-2227.2008.00648.X
P407
P577
2008-04-01T00:00:00Z